The three-dimensional X-ray crystal structure of carboxypeptidase A, a zinc-dependent hydrolase, covalently modified by a mechanism-based thiirane inactivator, 2-benzyl-3,4-epithiobutanoic acid, has been solved to 1.38 Å resolution. The interaction of the thiirane moiety of the inhibitor with the active site zinc ion promotes its covalent modification of Glu-270 with the attendant opening of the thiirane ring. The crystal structure determination at high resolution allowed for the clear visualization of the covalent ester bond to the glutamate side chain. The newly generated thiol from the inhibitor binds to the catalytic zinc ion in a monodentate manner, inducing a change in the zinc ion geometry and coordination, while its benzyl group fits into the S1' specificity pocket of the enzyme. The inhibitor molecule is distorted at the position of the carbon atom that is involved in the ester bond linkage on one side and the zinc coordination on the other. This particular type of thiirane-based metalloprotease inhibitor is for the first time analyzed in complex to the target protease at high resolution and may be used as a general model for zinc-dependent proteases.Key words: M14 family of proteases, mechanism-based inactivation, metallopeptidase, thiirane, X-ray crystallography Metalloproteases from the M14 family (carboxypeptidases, CPs) are involved in many physiologic and pathological processes such as tissue organogenesis (1-3), acute pancreatitis (4,5), diabetes (6,7), inflammation (8,9), fibrinolysis (10,11), neurologic diseases (12), and cancer (13-16). Circulating forms of CP may be used as prognostic tools for the early detection of cancer and other diseases (17). The M14 family of proteases comprises an extended and complex array of zinc-dependent proteins with wide genomic distribution (18-20). They share with matrix metalloproteases (MMPs; e.g., gelatinases, collagenases, matrilysins, and stromelysins) a similar catalytic mechanism, whereby the catalytic zinc ion predisposes the substrate to turnover with the involvement of a conserved glutamate residue in the active site (21). Notwithstanding the shared features of their respective mechanisms, MMPs are endopeptidases, whereas CPs are exopeptidases that remove the C-terminal residues from peptide substrates.Most known small-molecule inhibitors of CPs are chelators of the active site zinc ion. These chelators are often non-discriminant, as their function hinges on coordination with metals. The limited selectivity among potent zinc chelators can be exemplified by thioldependent CP inhibitors, such as 1 (2-mercaptomethyl-3-guanidinoethylthiopropanoic acid, Plummer's inhibitor (22)), which was still found to inhibit other M14 proteases (23). A similar concern has been encountered in the development of MMP inhibitors with subtype selectivity (24). Mechanism-based inactivators ('suicide substrate' or 'k cat inactivator') exploit features of the catalytic mechanisms of the targetted enzymes (25). An innocuous agent is converted to the inhibitory species only wit...